Neurology, 101:e2138-e2150
Addiction Steady support for healing $ 2,999 Addiction Recovery Package 10-session therapy with high-dose NAD+ to support brain function and ease withdrawal effects
But none of these share retatrutide's triple-agonist mechanism, and none have produced Phase 2 weight loss data that approaches the 24% benchmark
The next generation of GLP-1s, which is expected to be launched next year, may demonstrate amplified effects that could include improved neuroprotection, Thiara says, but its impact would need to be validated through rigorous clinical trials, she stated
In fact, I would argue convenience is a big friend to GLP-1 consumers. Recent GLP-1 research by Circana found the average user is on the medication between three to six months, and those three to six months are so incredibly important because the other thing that happens is they embrace the food and beverage changes during that time frame more than any other time frame (on GLP-1 medication), Lyons Wyatt said
